Personas / Equipo Humano

Marçal Pastor-Anglada

Buscador de publicaciones

Publicaciones

  • Martinez-Becerra P, Monte I, Romero MR, Serrano MA, Vaquero J, Macias RI, Del Rio A, Grañé-Boladeras N, Jimenez F, San-Martin FG, Pastor-Anglada M and Marin JJ.

    Up-regulation of FXR isoforms is not required for stimulation of the expression of genes involved in the lack of response of colon cancer to chemotherapy.

    PHARMACOLOGICAL RESEARCH . 66(5): 419-427. Nº de citas: 10

    [doi:10.1016/j.phrs.2012.07.005]

  • Trigueros-Motos L, Perez-Torras S, Casado FJ, Molina-Arcas M and Pastor-Anglada M.

    Aquaporin 3 (AQP3) participates in the cytotoxic response to nucleoside-derived drugs.

    BMC Cancer . 12: 434-434. Nº de citas: 31

    [doi:10.1186/1471-2407-12-434]

  • Errasti-Murugarren E, Fernández-Calotti P, Veyhl-Wichmann M, Diepold M, Pinilla-Macua I, Perez-Torras S, Kipp H, Koepsell H and Pastor-Anglada M.

    Role of the transporter regulator protein (RS1) in the modulation of concentrative nucleoside transporters (CNTs) in epithelia.

    MOLECULAR PHARMACOLOGY . 82(1): 59-67. Nº de citas: 12

    [doi:10.1124/mol.111.076992]

  • Martinez-Becerra P, Vaquero J, Romero MR, Lozano E, Anadon C, Macias RI, Serrano MA, Grañé-Boladeras N, Muñoz-Bellvis L, Alvarez L, Sangro B, Pastor-Anglada M and Marin JJ.

    No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors.

    MOLECULAR PHARMACEUTICS . 9(6): 1693-1704. Nº de citas: 70

    [doi:10.1021/mp300028a]

  • Fernández-Calotti PX, Lopez-Guerra M, Colomer D and Pastor-Anglada M.

    Enhancement of fludarabine sensitivity by all-trans-retinoic acid in chronic lymphocytic leukemia cells.

    HAEMATOLOGICA . 97(6): 943-951. Nº de citas: 16

    [doi:10.3324/haematol.2011.051557]

  • Guillén-Gómez E, Pinilla-Macua I, Perez-Torras S, Choi DS, Arce Y, Ballarín JA, Pastor-Anglada M and Díaz-Encarnación MM.

    New role of the human equilibrative nucleoside transporter 1 (hENT1) in epithelial-to-mesenchymal transition in renal tubular cells.

    J CELL PHYSIOL . 227(4): 1521-1528. Nº de citas: 18

    [doi:10.1002/jcp.22869]

  • Pinilla-Macua I, Casado FJ and Pastor-Anglada M.

    Structural determinants for rCNT2 sorting to the plasma membrane of polarized and non-polarized cells.

    BIOCHEMICAL JOURNAL . 442(3): 517-525. Nº de citas: 6

    [doi:10.1042/BJ20110605]

  • Cano-Soldado P and Pastor-Anglada M.

    Transporters that translocate nucleosides and structural similar drugs: structural requirements for substrate recognition.

    MEDICINAL RESEARCH REVIEWS . 32(2): 428-457. Nº de citas: 52

    [doi:10.1002/med.20221]

  • Bolze A, Abhyankar A, Grant AV, Patel B, Yadav R, Byun M, Caillez D, Emile JF, Pastor-Anglada M, Abel L, Puel A, Govindarajan R, de Pontual L and Casanova JL.

    A mild form of SLC29A3 disorder: a frameshift deletion leads to the paradoxical translation of an otherwise noncoding mRNA splice variant.

    PLoS One . 7(1): . Nº de citas: 48

    [doi:10.1371/journal.pone.0029708]

  • Cano-Soldado P, Gorraitz E, Errasti-Murugarren E, Casado FJ, Lostao MP and Pastor-Anglada M.

    Functional analysis of the human concentrative nucleoside transporter-1 variant hCNT1S546P provides insight into the sodium-binding pocket.

    AM J PHYSIOL-CELL PH . 302(1): . Nº de citas: 12

    [doi:10.1152/ajpcell.00198.2011]